BioFlash, an air sampler from Smiths Detection, can
detect SARS-CoV-2 variants including the Alpha variant (B.1.1.7),
Beta variant (B.1.351), Gamma variant (P.1), the Kappa variant
(B1.617.1), Delta (B.1.617.2) and Delta plus variant
(B.1.617.2.1).
The company is currently confirming the ability to
detect the Lambda variant, with results expected within a few
weeks.
“Emerging variants are a threat to pandemic
recovery; however, mitigation strategies that utilize BioFlash
will have an advantage” said Warren Mino, Managing Director,
Smiths Detection. “BioFlash works by collecting aerosols and
identifies the presence of dangerous pathogens using sensitive,
specific and rapid detection in near-real time without laboratory
analysis. Not only can BioFlash detect COVID19 and its variants,
it can be used by anyone, giving them immediate results, in
minutes not days, which helps stop the spread of COVID19 and
other airborne pathogens.”
The United States Army of Medical Research
Institute of Infectious Diseases (USAMRIID) has confirmed
that
BioFlash was capable of detecting airborne SARS-CoV-2.
The device has been used by several
Universities to stop the spread of COVID19 following airborne
detection in several campus buildings.
“It has been a great asset to have this equipment
at UMBC. As everyone knows, you need a layered protection strategy
to combat COVID. BioFlash is easy and fast to use which makes it a
critical part of our mitigation strategy to help prevent
transmission,” said Mike Pound, Director of Environmental Health
and Safety for University of Maryland, Baltimore County (UMBC).
See latest
Travel Industry News,
Video
Interviews,
Pictures,
Podcasts
and other
news regarding:
Smiths Detection,
COVID19,
Security.
Headlines: |
|
|